Repligen (RGEN) Gains from Sales and Divestitures (2017 - 2026)
Repligen (RGEN) reported Gains from Sales and Divestitures of $116798.0 for Q1 2026, up 14.69% year-over-year from $101837.0 in Q1 2025, and down 25.18% quarter-over-quarter from $156115.0 in Q4 2025.
Repligen (RGEN) Gains from Sales and Divestitures (2017 - 2026) Analysis & Trends
Repligen (RGEN) has 8 years of Gains from Sales and Divestitures data on file, last reported at $116798.0 in Q1 2026.
- Gains from Sales and Divestitures for Q1 2026 came in at $116798.0, up 14.69% year-over-year; the trailing twelve-month figure through Mar 2026 was $116798.0 (up 14.69% YoY), and the FY2025 annual result was $156115.0, up 5.18% from the prior year.
- Gains from Sales and Divestitures eased to $116798.0 in Q1 2026 per RGEN's latest filing, from $156115.0 in the prior quarter.
- Over five years, Gains from Sales and Divestitures peaked at $208531.0 in Q4 2022 and troughed at $98246.0 in Q1 2024.
- A 5-year average of $147172.4 and a median of $139681.0 in 2025 frame the typical range for Gains from Sales and Divestitures.
- The sharpest annual moves came in 2024 and 2026: Gains from Sales and Divestitures retreated 24.14% in 2024, then increased 14.69% in 2026.
- A 5-year view of Gains from Sales and Divestitures shows it stood at $208531.0 in 2022, then declined by 6.17% to $195672.0 in 2023, then dropped by 24.14% to $148429.0 in 2024, then gained by 5.18% to $156115.0 in 2025, then fell by 25.18% to $116798.0 in 2026.
- Business Quant data shows RGEN's Gains from Sales and Divestitures at $116798.0 in Q1 2026, $156115.0 in Q4 2025, and $139681.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn |
| 10 | Repligen | 7.41 Bn | 6.42 Bn | 108.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 116,798.00 |
| Mar 31, 2026 | 116,798.00 |
| Dec 31, 2025 | 156,115.00 |
| Dec 31, 2025 | 156,115.00 |
| Sep 30, 2025 | 139,681.00 |
| Sep 30, 2025 | 139,681.00 |
| Jun 30, 2025 | 122,517.00 |
| Jun 30, 2025 | 122,517.00 |
| Mar 31, 2025 | 101,837.00 |
| Mar 31, 2025 | 101,837.00 |
| Dec 31, 2024 | 148,429.00 |
| Dec 31, 2024 | 148,429.00 |
| Sep 30, 2024 | 137,072.00 |
| Sep 30, 2024 | 137,072.00 |
| Jun 30, 2024 | 125,820.00 |
| Jun 30, 2024 | 125,820.00 |
| Mar 31, 2024 | 98,246.00 |
| Mar 31, 2024 | 98,246.00 |
| Dec 31, 2023 | 195,672.00 |
| Dec 31, 2023 | 195,672.00 |